Approval · Notice of Compliance 21471 · 2018
DUTASTERIDE CAPSULES: Notice of Compliance 21471
Issued October 29, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21471
- Date
- October 29, 2018
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Change in product ownership
- Canadian reference product
- AVODART (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DUTASTERIDE CAPSULES | 02427842 | Approved |
Medicinal ingredients
- DUTASTERIDE 0.5 MG per CAP